/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Vivos Therapeutics Inc Share Price Today: Live Updates & Key Insights

Vivos Therapeutics Inc share price today is $1.34, up -2.99%. The stock opened at $1.31 against the previous close of $1.34, with an intraday high of $1.37 and low of $1.3.

Vivos Therapeutics Inc Share Price Chart

style
pb-0

Vivos Therapeutics Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Vivos Therapeutics Inc Share Price Performance

$1.34 -0.0299(-2.99%) VVOS at 13 Mar 2026 03:50 PM Medical Devices
Lowest Today 1.3
Highest Today 1.37
Today’s Open 1.31
Prev. Close 1.34
52 Week High 7.95
52 Week Low 1.26
Day’s Range: Low 1.3 High 1.37
52-Week Range: Low 1.26 High 7.95
1 day return -
1 Week return -2.98
1 month return -13.9
3 month return -35.96
6 month return -61.3
1 year return -59.24
3 year return -85.14
5 year return -99.29
10 year return -

Vivos Therapeutics Inc Institutional Holdings

Vanguard Group Inc 2.91

Vanguard Total Stock Mkt Idx Inv 2.03

Strategic Wealth Designers 0.96

Vanguard Institutional Extnd Mkt Idx Tr 0.58

Geode Capital Management, LLC 0.51

National Asset Management Inc 0.42

DRW Securities, LLC 0.40

Commonwealth Equity Services Inc 0.39

Fidelity Extended Market Index 0.31

Blackrock Extended Mkt Fund CF 0.27

BlackRock Inc 0.27

State Street Corp 0.24

Extended Equity Market Fund K 0.23

Acorn Wealth Advisors, LLC 0.14

Northern Trust Corp 0.12

Fidelity Total Market Index 0.12

Fidelity Series Total Market Index 0.08

Vanguard Instl Ttl Stck Mkt Idx Tr 0.07

NT Ext Equity Mkt Idx Fd - NL 0.07

Northern Trust Extended Eq Market Idx 0.05

NT Ext Equity Mkt Idx Fd - L 0.05

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.05

Spartan Total Market Index Pool G 0.04

Tower Research Capital LLC 0.03

Extended Equity Market Fund M 0.03

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.02

Advisor Group Holdings, Inc. 0.01

Morgan Stanley - Brokerage Accounts 0.01

SignatureFD, LLC 0.01

State St US Extended Mkt Indx NL Cl C 0.00

Ronald Blue Trust, Inc. 0.00

Bank of America Corp 0.00

Spartan Extended Market Index Pool F 0.00

UBS Group AG 0.00

State St US Ttl Mkt Indx NL Cl A 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

Kozak & Associates, Inc. 0.00

Global Retirement Partners, LLC. 0.00

Royal Bank of Canada 0.00

Vivos Therapeutics Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Vivos Therapeutics Inc Fundamentals

Market Cap 15.30 M

PB Ratio 5.5605

PE Ratio 0.0

Enterprise Value 23.44 M

Total Assets 15.28 M

Volume 80866

Vivos Therapeutics Inc Company Financials

Annual Revenue FY24:13801000 13.8M, FY23:14503000 14.5M, FY22:16024000 16.0M, FY21:16885000 16.9M, FY20:13066237 13.1M

Annual Profit FY24:8271000 8.3M, FY23:8717000 8.7M, FY22:10019000 10.0M, FY21:12604000 12.6M, FY20:10412808 10.4M

Annual Net worth FY24:-13583000 -13.6M, FY23:-15413000 -15.4M, FY22:-22659000 -22.7M, FY21:-20293000 -20.3M, FY20:-8822879 -8.8M

Quarterly Revenue Q3/2025:6783000 6.8M, Q2/2025:3820000 3.8M, Q1/2025:3016000 3.0M, Q3/2024:3860000 3.9M, Q2/2024:4054000 4.1M

Quarterly Profit Q3/2025:3937000 3.9M, Q2/2025:2110000 2.1M, Q1/2025:1509000 1.5M, Q3/2024:2334000 2.3M, Q2/2024:2651000 2.7M

Quarterly Net worth Q3/2025:-5400000 -5.4M, Q2/2025:-5013000 -5.0M, Q1/2025:-3864000 -3.9M, Q3/2024:-2616000 -2.6M, Q2/2024:-1930000 -1.9M

About Vivos Therapeutics Inc & investment objective

Company Information Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

Organisation Medical Devices

Employees 262

Industry Medical Devices

CEO Mr. R. Kirk Huntsman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow